For coagulation tests and as a rinsing solution for the sample needles of the Sy
For coagulation tests and as a rinsing solution for the sample needles of the Sysmex® CA Systems
N/T Protein Control SL/M is a medium level, multi-analyte control for use as acc
N/T Protein Control SL/M is a medium level, multi-analyte control for use as accuracy and precision control in the determination of human serum proteins by immunonephelometry with the BN Systems
N/T Protein Control SL/H is a high level, multi-analyte control for use as accur
N/T Protein Control SL/H is a high level, multi-analyte control for use as accuracy and precision control in the determination of human serum proteins by immunonephelometry with the BN Systems
For the determination of the activity of coagulation factor X in human plasma by
For the determination of the activity of coagulation factor X in human plasma by coagulometric methods
For the determination of the activity of coagulation factor XI in human plasma b
For the determination of the activity of coagulation factor XI in human plasma by coagulometric methods
Quantitative determination of soluble transferrin receptor (sTfR) in human serum
Quantitative determination of soluble transferrin receptor (sTfR) in human serum and heparinized plasma on BN Systems
LA 1 Screening Reagent. Simplified DRVV reagent to screen for the presence of Lu
LA 1 Screening Reagent. Simplified DRVV reagent to screen for the presence of Lupus Anticoagulants
For use as a low level assayed control for the quantitative measurement of low m
For use as a low level assayed control for the quantitative measurement of low molecular weight heparin with Berichrom Heparin
For calibration of the Berichrom Heparin assay for measurement of low molecular
For calibration of the Berichrom Heparin assay for measurement of low molecular weight heparin
JPA
SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES
For use as a high level assayed control for the quantitative measurement of unfr
For use as a high level assayed control for the quantitative measurement of unfractionated heparin with Berichrom Heparin
Quantitative determination of homocysteine in human serum and plasma on BN II an
Quantitative determination of homocysteine in human serum and plasma on BN II and BN ProSpec® Systems
CYSC CON L is an assayed intralaboratory quality control for assessment of preci
CYSC CON L is an assayed intralaboratory quality control for assessment of precision and analytical bias in the determination of the CYSC method on the Dimension Vista® System
PROT1 CON M is an assayed, mid-level, intralaboratory, multi-analyte quality con
PROT1 CON M is an assayed, mid-level, intralaboratory, multi-analyte quality control for the assessment of precision and analytical bias on the Dimension Vista® System
For the quantitative measurement of immunoglobulin E in human serum and plasma (
For the quantitative measurement of immunoglobulin E in human serum and plasma (heparin or EDTA) on the Dimension Vista® System
DGC
IGE, ANTIGEN, ANTISERUM, CONTROL
DImension Vista® Immunoglobulin E Flex® reagent cartridge
For the quantitative measurement of C-reactive protein in human serum and plasma
For the quantitative measurement of C-reactive protein in human serum and plasma on the Dimension Vista® System
NQD
CARDIAC C-REACTIVE PROTEIN, ANTIGEN, ANTISERUM, AND CONTROL
For the quantitative measurement of total homocysteine in human serum and plasma
For the quantitative measurement of total homocysteine in human serum and plasma on the Dimension Vista® System
The DIMERTEST® Latex Assay is intended for the rapid qualitative or semiquantita
The DIMERTEST® Latex Assay is intended for the rapid qualitative or semiquantitative evaluation of circulating derivatives of cross-linked fibrin degradation products (XL-FDP) in human plasma
DAP
FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL
For differential staining in hematology that gives results similar to a Wright-G
For differential staining in hematology that gives results similar to a Wright-Giemsa stain
Assayed accuracy and precision controls in the determination of free light chain
Assayed accuracy and precision controls in the determination of free light chains (FLC) type kappa and type lambda on BN Systems.
Assayed accuracy and precision controls in the determination of free light chain
Assayed accuracy and precision controls in the determination of free light chains (FLC) type kappa and type lambda on BN Systems.
The BN ProSpec® is a system for the quantitative determination of proteins in se
The BN ProSpec® is a system for the quantitative determination of proteins in serum, plasma, urine and CSF
Quantitative determination of carbohydrate-deficient transferrin (CDT) in human
Quantitative determination of carbohydrate-deficient transferrin (CDT) in human serum on BN II and BN ProSpec® Systems
Qualitative detection or semi-quantitative determination of C-reactive protein (
Qualitative detection or semi-quantitative determination of C-reactive protein (CRP) in human serum
Qualitative detection or semi-quantitative determination of C-reactive protein (
Qualitative detection or semi-quantitative determination of C-reactive protein (CRP) in human serum
Qualitative detection or semi-quantitative determination of C-reactive protein (
Qualitative detection or semi-quantitative determination of C-reactive protein (CRP) in human serum
REAADS Coagulation Control 2 (CC-2) ) is an assayed control plasma in coagulatio
REAADS Coagulation Control 2 (CC-2) ) is an assayed control plasma in coagulation studies for In Vitro Diagnostic Use.PRINCIPLE OF THE PROCEDURECoagulation Control 2 is tested in the same manner as citrated patient plasma samples to assess the performance of each assay run, for the parameters. Testing variables in each laboratory, including equipment, reagents, and technique may influence control recovery. Although an expected range is provided for each parameter, laboratories should establish their own expected range for their particular instrument-reagent system. Refer to Package Insert.
Assayed control used to monitor the performance of coagulation assays in the pat
Assayed control used to monitor the performance of coagulation assays in the pathological range
LA Control Low is a low positive control plasma for use in Lupus Anticoagulant c
LA Control Low is a low positive control plasma for use in Lupus Anticoagulant clotting test assays, specifically LA 1 Screening Reagent (DRVVT) and LA 2 Confirmation Reagent (DRVVT) from Siemens Healthcare Diagnostics on automated coagulation analyzers
LA Control High is a high positive control plasma for use in Lupus Anticoagulant
LA Control High is a high positive control plasma for use in Lupus Anticoagulant clotting test assays, specifically LA 1 Screening Reagent (DRVVT) and LA 2 Confirmation Reagent (DRVVT) from Siemens Healthcare Diagnostics on automated coagulation analyzers
For use as a high level assayed control for the quantitative measurement of low
For use as a high level assayed control for the quantitative measurement of low molecular weight heparin with Berichrom Heparin
For use as a high level assayed control for the quantitative measurement of unfr
For use as a high level assayed control for the quantitative measurement of unfractionated heparin with Berichrom Heparin
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for the listed constituents.
George King Factor XIII Deficient plasma is fresh frozen human plasma derived fr
George King Factor XIII Deficient plasma is fresh frozen human plasma derived from a congenital Factor XIII deficient donor.
George King Positive Lupus Anticoagulant is citrated fresh frozen human plasma d
George King Positive Lupus Anticoagulant is citrated fresh frozen human plasma derived from donors who have been diagnosed with the Anti-Phospholipid Antibody Syndrome (APS).
George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma d
George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma derived from donors who have been diagnosed with the Anti-Phospholipid Antibody Syndrome (APS).
George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 20
George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 20 vials of select control material that can be used to correlate reagent lot numbers and/or instrument platforms. (individual product inserts are included with each kit)
George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 10
George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 10 vials of select control material that can be used to correlate reagent lot numbers and/or instrument platforms. (individual product inserts are included with each kit)
George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma d
George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma derived from a congenital Factor XIII deficient donor.
George King von Willebrand, Type 2B, is citrated human fresh frozen plasma deriv
George King von Willebrand, Type 2B, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2B. This plasma is intended for use as a control in the quantitative determination of von Willebrand aG in citrated plasma.
George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma
George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 1. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.
George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma d
George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma derived from a congenital Factor XIII deficient donor.
George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasm
George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.
George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasm
George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.
George King von Willebrand plasma, Type 2A, is a citrated human fresh frozen pla
George King von Willebrand plasma, Type 2A, is a citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.
George King von Willebrand plasma, Type 3, is citrated human fresh frozen plasma
George King von Willebrand plasma, Type 3, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 3. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma.
George King von Willebrand plasma, Type 2B, is a citrated human fresh frozen pla
George King von Willebrand plasma, Type 2B, is a citrated human fresh frozen plasma derived from a donor diagnosed with vWD type 2B. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma
George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma
George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 1. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma.
George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma d
George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma derived from donors who have been diagnosed with the Anti-Phospholipid Antibody Syndrome (APS).